Patients with cancers of the mid- and lower throat may have higher survival rates if their initial treatment includes surgery, according to new research presented to the 2015 European Cancer Congress.

Researchers told the Congress that a nationwide study in Taiwan found that, five years after diagnosis, radical surgery was associated with significant overall survival benefits among patients whose cancers of the throat had started to spread. However, fewer than half of the patients in the study received surgery.

Dr Chih-Tao Cheng, MD, a medical researcher at the Koo Foundation Sun Yat-Sen Cancer Center in Taipei City, Taiwan, said:

Caesarean delivery was not associated with decrease in the at-birth fracture rates in infants with osteogenesis imperfecta, a rare bone disorder, said a consortium of researchers led by Baylor College of Medicine.

The new research is the first study to come from the Brittle Bone Disorders Consortium, a new National Institutes of Health collaborative clinical research network focused on brittle bone disorders such as osteogenesis imperfecta.

Osteogenesis imperfecta is a connective tissue disorder that affects approximately 1 in 15,000 people. The major clinical feature of the disorder is increased fragility of bone, which leads to recurrent fractures and bone deformities. In the severe forms of the disorder, fractures occur in utero. With increased availability of prenatal ultrasound examination and genetic testing, many are diagnosed before birth.

 

Five billion people worldwide do not have access to safe and affordable surgery and anesthesia when they need it. As a consequence, millions of people are dying from common, easily treatable conditions like appendicitis, fractures, or obstructed labour. This is according to a major new Commission co-led by experts at King

The Edison Awards, celebrating 28 years of honoring the best in innovation and excellence in the development of new products and services, announced today that the Barco Coronis Uniti

A Massachusetts General Hospital (MGH)-developed system for determining which patients with severe strokes are most likely to benefit from catheter-based systems for blood clot removal led to a greater percentage of screened patients receiving treatment and to outcomes similar to recent studies that found significant treatment benefits. The research team reports how the precision of their classification system, which combines diffusion MRI with key clinical characteristics, more than doubled the percentage of screened patients who were assigned to and probably benefited from treatment.